Lavomax, pills 125mg, 3pcs

Composition

One tablet contains: The core: Active ingredient: Tilorone dihydrochloride-125 mg; Excipients: Magnesium Hydroxycarbonate (heavy magnesium carbonate), Povidone K 30, Calcium Stearate; Shell: Sucrose, Povidone K 17, Copovidone, Magnesium hydroxycarbonate (light magnesium carbonate), Titanium dioxide, Colloidal silicon dioxide (aerosil A-380), Quinoline yellow dye, Sunset yellow dye, Macrogol-6000, Beeswax, Liquid paraffin, Talc.

Pharmacological action

Low molecular weight synthetic interferon inducer that stimulates the formation of all types of interferons (alpha, beta, gamma and lambda) in the body. The main producers of interferon in response to the introduction of tiloron are intestinal epithelial cells, hepatocytes, T-lymphocytes, neutrophils and granulocytes. After oral use, the maximum production of interferon is determined in the gut — liver — blood sequence after 4-24 hours. Tiloron has an immunomodulatory and antiviral effect. According to experimental studies, after a single oral use of tilorone at a dose equivalent to the maximum daily dose for humans, the maximum concentration in the lung tissue of interferon lambda is determined after 24 hours, interferon alpha – after 48 hours. Induction of interferon lambda in the lung tissue increases the antiviral protection of the respiratory tract in influenza and other respiratory viral infections. In human leukocytes, it induces the synthesis of interferon. It stimulates bone marrow stem cells, increases antibody formation depending on the dose, reduces the degree of immunosuppression, and restores the ratio of T-suppressors and T-helpers. It is effective against various viral infections, including influenza viruses, other acute respiratory viral infections, hepatitis viruses and herpesviruses. The mechanism of antiviral action is associated with the inhibition of translation of virus-specific proteins in infected cells, as a result of which viral reproduction is suppressed.

Active ingredients

Tiloron

Indications

As part of complex therapy in adults: treatment of influenza and other acute respiratory viral infections; treatment of herpetic infection. prevention of influenza and other acute respiratory infections in adults.

Contraindications

Hypersensitivity to the drug. The period of pregnancy and lactation. Children’s age (up to 18 years). Sucrose/isomaltase deficiency, fructose intolerance, glucose-galactose malabsorption (the drug contains sucrose).

Side effects

Possible allergic reactions, dyspeptic phenomena, short-term chills. If any of the side effects listed in the instructions get worse, or you notice any other side effects not listed in the instructions, tell your doctor.

Interaction

Compatible with antibiotics and traditional treatments for viral and bacterial diseases.

There was no clinically significant interaction of Lavomax with antibiotics and traditional treatments for viral and bacterial diseases.

How to take, course of use and dosage

The drug is taken orally, after a meal. For the treatment of influenza and other acute respiratory infections-125 mg per day for the first 2 days of treatment, then 125 mg after 48 hours. For the course-750 mg (6 tablets). For the prevention of influenza and other acute respiratory viral infections-125 mg 1 time a week for 6 weeks. For the course-750 mg (6 tablets). For the treatment of herpetic infection – the first two days of 125 mg, then after 48 hours of 125 mg. The course dose is 1.25-2.5 g (10-20 tablets). When treating influenza and other acute respiratory viral infections, if symptoms persist for more than 4 days, you should consult a doctor.

Overdose

Cases of Lavomax overdose are unknown.

Description

Antiviral immunostimulating agent-inducer of interferon formation

Description

Coated tablets, yellow to orange in color, round in shape. The core of the tablet is orange in color.

Functional features

After oral use, tilorone is rapidly absorbed from the gastrointestinal tract. Bioavailability is 60%. About 80% of tilorone binds to plasma proteins. Tiloron is excreted almost unchanged in the feces (70%) and urine (9%). The elimination half-life is 48 hours. Tilorone does not undergo biotransformation and does not accumulate in the body.

Complete set

Film-coated tablets,125 mg. 3,4,6 or 10 tablets in a contour cell package. One or two contour cell packages together with instructions for medical use of the drug are placed in a cardboard pack.

Special instructions

Influence on the ability to drive vehicles and work with mechanisms The use of the drug does not affect the ability to drive vehicles and engage in other potentially dangerous activities that require increased concentration of attention and speed of psychomotor reactions.

Form of production

Coated tablets, yellow to orange in color, round in shape.

The cross-section shows 2 layers. The core of the tablet is orange in color.

Storage conditions

Store in a dry place protected from light at a temperature not exceeding 25 °C. Keep out of reach of children.

Shelf

life is 2 years. Do not use the product after the expiration date.

Active ingredient

Tiloron

Dosage form

Tablets